A detailed history of Central Pacific Bank Trust Division transactions in Abb Vie Inc. stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 13,782 shares of ABBV stock, worth $2.5 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
13,782
Previous 11,526 19.57%
Holding current value
$2.5 Million
Previous $1.98 Billion 37.67%
% of portfolio
0.34%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

BUY
$163.84 - $199.33 $369,623 - $449,688
2,256 Added 19.57%
13,782 $2.72 Billion
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $445,330 - $520,046
-2,877 Reduced 19.98%
11,526 $1.98 Billion
Q1 2024

May 02, 2024

BUY
$159.82 - $182.1 $2.3 Million - $2.62 Million
14,403 New
14,403 $2.6 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Central Pacific Bank Trust Division Portfolio

Follow Central Pacific Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Pacific Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Central Pacific Bank Trust Division with notifications on news.